2024
Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US
Kerekes D, Frey A, Prsic E, Tran T, Clune J, Sznol M, Kluger H, Forman H, Becher R, Olino K, Khan S. Immunotherapy Initiation at the End of Life in Patients With Metastatic Cancer in the US. JAMA Oncology 2024, 10: 342-351. PMID: 38175659, PMCID: PMC10767643, DOI: 10.1001/jamaoncol.2023.6025.Peer-Reviewed Original ResearchNon-small cell lung cancerEnd of lifeMonth of deathImmunotherapy initiationCohort studyMAIN OUTCOMEStage IV non-small cell lung cancerCharlson-Deyo comorbidity indexHigh metastatic burdenInitiation of immunotherapyNational prescribing patternsRisk-adjusted patientsImmune checkpoint inhibitorsRetrospective cohort studyStage IV melanomaPercentage of patientsHigh-volume centersLocation of metastasesLow-volume centersOdds of deathCell lung cancerNational Clinical DatabaseLow-volume facilitiesDrug Administration approvalCheckpoint inhibitors
2015
Outpatient palliative care encounters in stage IV lung cancer care: An institutional review.
Rizk S, Prsic E, Rafelson W, Reagan J, Taber A. Outpatient palliative care encounters in stage IV lung cancer care: An institutional review. Journal Of Clinical Oncology 2015, 33: 128-128. DOI: 10.1200/jco.2015.33.29_suppl.128.Peer-Reviewed Original ResearchNon-small cell lung cancerStandard oncologic careStage IV non-small cell lung cancerPalliative carePC interventionsOverall survivalSick visitsRetrospective analysisPC groupLung cancer carePalliative care encountersUtilization of emergencyLines of chemotherapyOutpatient palliative careReceipt of chemotherapyEmergency department visitsCell lung cancerCommon practice patternsStudy inclusion criteriaSignificant differencesPC encountersHospice referralDepartment visitsMultidisciplinary clinicOncologic care